Outlook Therapeutics, Inc. OTLK

For those of you that don’t understand what just happened. BLA has three parts to get approved 1)CMC which cleared last time they went for BLA 2) Proof of efficacy and safety. The FDA appeal just approved 3) approved labeling within verbiage on how to use product. The resubmitted BLA is little more than a formality for approval. For all general purposes this is an approved medication to an 8 billion dollar market half of which is already using this medication off label in compounding pharmacies. The approval will create a patent that will stop compounding and force $4 billion dollars of instant revenue. This is a close to a guarantee you can get to making money.

It is common practice for companies to go silent when negotiations are happening in a buyout, merger or partnership. I think that whatever deal is in the works is pending on the FDA response.

OTLK is not for sale. There will be a strategic partnership where another company will buy the rights to the US market. It can be structured many different ways and most likely to favor the purchaser. They will put up the money for a new 3 month study with end point at 12 weeks and about $60 million in cash to float OTLK another year and time to grow sales in the $8.7 billion dollar EU market. If successful with FDA and sales grow in EU a final bid to buy out OTLK will happen first of 2027. This is a screaming deal for the new partner and gives time to create value for long term stock holder.

You self serving, short sided traders will say anything to scare people out of their stock. Fear……, for the day of “RECKONING” grows near.

“Nothing to fear but fear itself”

No one has any info to make any accurate assumptions, pro or con. Those who claim to are Charlatans. I have seen some wild claims by those who have self serving interest.

I’m not able to log in to ST. Let’s have a great day!!?

The volume is high because the European market allow is worth way more than $2.00.
Get over the FDA delay. Think about what OTLK has today and quit worrying about the gravity tomorrow.

https://www.aol.com/fda-rejects-outlook-therapeutics-eye-171540452.html

How far did the shorts drive the price down enough to sell 100% of the stock again that is a large artificial supply. Keeping in mind that the vast majority of this company is owned by insiders and institutions and none of them have sold any of theirs shares think about the volume of shorts driving the price down two dollars was never the price the company is worth substantially more just out of what’s coming out of Europe. If you sell today you are forever the fool.